| Date Filed | Type | Description |
| 08/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/04/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/04/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
8-K
| Quarterly results |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/02/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/02/2023 |
8-K
| Quarterly results |
| 03/01/2023 |
4
| Mayer Timothy (COO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Kundu Sourav (Sr VP, Dev. & Mfg.) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
|
|
| 03/01/2023 |
4
| Myint Han (Chief Medical Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Shaw Kevin G. (Sr VP, Legal Affairs) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
|
|
| 03/01/2023 |
4
| Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 309,000 options to buy
@ $1.55, valued at
$479k
|
|
| 03/01/2023 |
4
| Cobourn Steven P. (CFO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 02/28/2023 |
3
| Shaw Kevin G. (Sr VP, Legal Affairs) has filed a Form 3 on NextCure, Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2023 |
SC 13G
| MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in NEXTCURE, INC. |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/04/2022 |
8-K
| Quarterly results |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Borgman Anne Elizabeth (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $4.77, valued at
$68k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
8-K
| Quarterly results |
|